Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Assets Average: 2009-2025

Historic Assets Average for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Sep 2025 value amounting to $66.9 million.

  • Cumberland Pharmaceuticals' Assets Average fell 13.82% to $66.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.9 million, marking a year-over-year decrease of 13.82%. This contributed to the annual value of $78.7 million for FY2024, which is 9.93% down from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Assets Average of $66.9 million as of Q3 2025, which was down 2.93% from $68.9 million recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Assets Average peaked at $94.9 million during Q1 2021, and registered a low of $66.9 million during Q3 2025.
  • Its 3-year average for Assets Average is $79.8 million, with a median of $80.0 million in 2024.
  • In the last 5 years, Cumberland Pharmaceuticals' Assets Average climbed by 6.78% in 2022 and then dropped by 13.86% in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Assets Average (Quarterly) stood at $86.0 million in 2021, then increased by 6.78% to $91.9 million in 2022, then dropped by 7.72% to $84.8 million in 2023, then declined by 10.14% to $76.2 million in 2024, then fell by 13.82% to $66.9 million in 2025.
  • Its Assets Average stands at $66.9 million for Q3 2025, versus $68.9 million for Q2 2025 and $72.8 million for Q1 2025.